At this time, product has not yet been returned and a valid serial number has not been provided.An extended investigation has been performed for the reported complaint, and there was no indication that the product did not meet specification.Clinical data was reviewed and confirmed that libre sensors continue to be safe, effective, and perform as intended in the field.A tripped trend review was conducted for the reported complaint and fs libre sensors; no trends were identified that would indicate any product related issues.If the product is returned, a physical investigation will be performed and a follow-up report submitted.The device manufacturing date is unknown.The date entered in section h4 is the date abbott diabetes care became aware of the event.All pertinent information available to abbott diabetes care has been submitted.
|
Abbott diabetes care (adc) received an mhra declaration in which a healthcare professional reported that a customer encountered an insertion issue with the adc device.The customer indicated that upon removal of the sensor, the applicator needle remained in their arm.The customer used tweezers to remove the needle but also observed redness, swelling, and "infection" at the placement site.The customer was contacted and indicated they applied savlon (antiseptic cream) to the site and had contact with an hcp who prescribed antibiotics for treatment.It was also reported that the hcp was considering "explorative minor surgery to see if there is still anything under the surface to be removed." however, there were no further reports of additional treatment.The customer indicated they have ceased use of the freestyle libre 2 system.There was no report of death or permanent impairment associated with this event.
|